Skip to main content
CDC Website

Health Professionals

New TB Treatment Guidelines: A Clinician's Guide to the ATS/CDC/ERS/IDSA 2025 Update

his webinar session features a case-based discussion on the management of tuberculosis in alignment with the 2025 ATS/CDC/ERS/IDSA Clinical Practice Guidelines. Lahari Tumuluri, MD (Tulane University), will present two TB cases illustrating the application of these guidelines. Jussi Saukkonen, MD (Boston University), and Charles Daley, MD (National Jewish), will review the guideline development process, supporting evidence, and practical implications for treating drug-sensitive and drug-resistant TB, drawing on real-world clinical experience.

Latent Tuberculosis Infection LTBI and Community Providers

The webinar is to enhance community medical providers’ awareness of latent tuberculosis infection (LTBI). A brief overview of latent tuberculosis vs. active tuberculosis is given along with the most recent numbers of TB cases in NYS and CDC estimates of those with LTBI. It encourages community providers to assess their patients for TB risk factors, then test and treat them for LTBI as indicated.

Estimating herd immunity thresholds for hepatitis A: A 16-state analysis to inform vaccination strategies among people who inject drugs (PWID)

This fact sheet discusses how research from the University of California San Diego and published in Clinical Infectious Diseases, estimates the hepatitis A vaccination coverage needed to prevent outbreaks among people who inject drugs (PWID). Analyzing surveillance data from 16 states with recent hepatitis A outbreaks linked to PWID, the study found that vaccination coverage of at least 80% may be necessary to reliably achieve herd immunity—though some states, such as West Virginia, may require higher levels.

Dr. Patrick Sullivan on PrEP 2024 - Higher State-level PrEP Coverage is associated with Declines in HIV Diagnoses

This webinar features a presentation from the March 2024 Conference on Retroviruses and Opportunistic Infections (CROI), where Dr. Patrick Sullivan—AIDSVu Principal Scientist and Professor at Emory University—presented the oral abstract, “Association of State-Level PrEP Coverage and State-Level HIV Diagnoses, US, 2012–2021.” Using real-world data on PrEP coverage, Dr. Sullivan’s study found that states with a higher proportion of people with PrEP indications who were using PrEP experienced steeper declines in new HIV diagnoses over the past decade.

Let's break it down: Breaking down hepatitis A

This webinar recording discusses how the hepatitis A landscape is changing globally. Between 2010 and 2019, the number of deaths from hepatitis A decreased globally by 10%, despite the number of cases increasing by 4%. A number of factors have helped drive these changes, including globalization and increased hepatitis A vaccination rates. 

Expanding Access to PrEP: A Toolkit for Sexual and Reproductive Health Providers

This toolkit is organized into flexible, standalone sections to meet the varied needs of Title X and SRH providers. You do not need to use the toolkit in order. The toolkit is organized by types of PrEP services so that the user can identify and access the tools and resources most relevant to the services provided in their setting. Whether you provide counseling and referrals or deliver the full spectrum of services onsite, the materials here are designed to support your work.

Congenital Syphilis and Heat Injuries

This webinar recording explores two critical public health topics: congenital syphilis and heat-related illnesses. Presenters provide an overview of current trends, prevention strategies, and treatment considerations for congenital syphilis, alongside guidance on recognizing, preventing, and managing heat injuries. The session offers practical insights for healthcare providers, public health professionals, and community partners working to address these urgent health concerns.